Shane Stenner, MD, MS, and Chase Webber, DO, and a collaborative team of experts at Vanderbilt University School of Medicine (VUSM) and Vanderbilt University Medical Center were recently named to receive the American Medical Association’s ChangeMedEd Innovation grant. 

African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.

Jane Case, DNP, APRN-BC, has been named associate vice chair for Advanced Practice for the Department of Medicine at Vanderbilt University Medical Center.

The 22nd annual Levi Watkins Jr., MD Lecture will be held Tuesday, Oct. 24, at noon in 208 Light Hall.

A Vanderbilt clinical trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva.

Vanderbilt University Medical Center has performed its first combined reoperative lung and kidney transplant.

A new study by Vanderbilt researchers provides a remarkably detailed view of the earliest events leading to the development of cancer, and of potential new ways to prevent it.